angiotensin ii has been researched along with Pneumococcal Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyoshi, K; Azegami, T; Hayashi, K; Hishikawa, A; Ishige, K; Itoh, H; Kiyono, H; Sawada, SI; Yuki, Y | 1 |
Nielsen, MS; Thomas, VL | 1 |
2 other study(ies) available for angiotensin ii and Pneumococcal Infections
Article | Year |
---|---|
Intranasal vaccination against angiotensin II type 1 receptor and pneumococcal surface protein A attenuates hypertension and pneumococcal infection in rodents.
Topics: Administration, Intranasal; Angiotensin II; Animals; Antibodies, Bacterial; Bacterial Proteins; Blood Pressure; Female; Hypertension; Immunization, Passive; Immunoglobulin G; Male; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Pneumococcal Vaccines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Streptococcus pneumoniae; Vaccination | 2018 |
Administration of angiotensin II in refractory septic shock.
Topics: Adult; Angiotensin II; Combined Modality Therapy; Critical Care; Drug Therapy, Combination; Female; Hemodynamics; Humans; Pneumococcal Infections; Sepsis; Shock, Septic | 1991 |